|
SETD8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.65223390524716E-12 |
| Normal-vs-Stage2 |
1.188910E-04 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
1.601970E-01 |
| Stage1-vs-Stage3 |
7.175600E-03 |
| Stage1-vs-Stage4 |
5.447500E-04 |
| Stage2-vs-Stage3 |
3.717100E-03 |
| Stage2-vs-Stage4 |
4.619600E-04 |
| Stage3-vs-Stage4 |
2.524400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
7.001000E-04 |
| Normal-vs-Asian |
1.91935356497197E-12 |
| Caucasian-vs-AfricanAmerican |
3.486600E-01 |
| Caucasian-vs-Asian |
7.361400E-01 |
| AfricanAmerican-vs-Asian |
2.985600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.32116539930394E-14 |
| Normal-vs-Female |
1.62470037423645E-12 |
| Male-vs-Female |
9.364200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62991842245219E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62880819942757E-12 |
| Normal-vs-Age(61-80Yrs) |
1.57907020792436E-12 |
| Normal-vs-Age(81-100Yrs) |
4.34200000000162E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.973200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.670600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.246600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.738200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.994600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.386600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.80233647187833E-13 |
| Classical-VS-Follicular |
3.96860000000387E-05 |
| Classical-VS-Other |
8.676400E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
2.44693154627385E-13 |
| Tall-VS-Other |
8.039800E-02 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
2.314000E-01 |
| Follicular-VS-Normal |
9.755200E-03 |
| Other-VS-Normal |
3.017100E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.48034925931506E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
4.10910000000486E-05 |
|
|
